Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
References
1. Rossi GP, Ceolotto G, Rossitto G, Seccia TM, Maiolino G, Berton C, et al. Prospective validation of an automated Chemiluminescence-based assay of renin and aldosterone for the work-up of arterial hypertension. Clin Chem Lab Med 2016;54:1441–50.10.1515/cclm-2015-1094Search in Google Scholar PubMed
2. Rossi GP, Sechi LA, Giacchetti G, Ronconi V, Strazzullo P, Funder JW. Primary aldosteronism: cardiovascular, renal and metabolic implications. Trends Endocrinol Metab 2008;19:88–90.10.1016/j.tem.2008.01.006Search in Google Scholar PubMed
3. Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, et al. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol 2006;48:2293–300.10.1016/j.jacc.2006.07.059Search in Google Scholar PubMed
4. Wu VC, Yang SY, Lin JW, Cheng BW, Kuo CC, Tsai CT, et al. Kidney impairment in primary aldosteronism. Clin Chim Acta 2011;412:1319–25.10.1016/j.cca.2011.02.018Search in Google Scholar PubMed
5. Lam L, Chiu WW, Davidson JS. Overestimation of aldosterone by immunoassay in renal impairment [Letter]. Clin Chem 2016;62:890–1.10.1373/clinchem.2016.255737Search in Google Scholar PubMed
6. Jones JC, Carter GD, MacGregor GA. Interference by polar metabolites in a direct radioimmunoassay for plasma aldosterone. Ann Clin Biochem 1981;18(Pt 1):54–9.10.1177/000456328101800111Search in Google Scholar PubMed
7. Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2016;101:1889–916.10.1210/jc.2015-4061Search in Google Scholar PubMed
8. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013;34:2159–219.10.1201/b17072-61Search in Google Scholar
©2017 Walter de Gruyter GmbH, Berlin/Boston